Population pharmacokinetic/pharmacodynamic modeling of drug-induced adverse effects of a novel homocamptothecin analog, elomotecan (BN80927), in a Phase I dose finding study in patients with advanced solid tumors
Trocóniz, Iñaki F., Cendrós, Josep-María, Soto, Elena, Pruñonosa, Joan, Perez-Mayoral, Ana, Peraire, Concepción, Principe, Paola, Delavault, Patrick, Cvitkovic, Frédérique, Lesimple, Thierry, Obach, Rosendo
Published in Cancer chemotherapy and pharmacology (01.08.2012)
Published in Cancer chemotherapy and pharmacology (01.08.2012)
Get full text
Journal Article